Deferiere Raphael
SEC insider (Form 3/4/5 filer). CIK 0002071320. Chief Accounting Officer at Centessa Pharmaceuticals plc (CNTA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in CHESHIRE.
Companies Deferiere Raphael has filed insider reports for
- Centessa Pharmaceuticals plc (CNTA): Officer, Chief Accounting Officer
Deferiere Raphael
CIK: 0002071320
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTA
Centessa Pharmaceuticals plc
Officer